Biogen

Sage rejects Biogen's $469 million takeover offer, says offer undervalues company
Yahoo/Reuters
Mon, 01/27/25 - 11:38 am
Biogen
SAGE Therapeutics
M&A
Biogen, Eisai Win Nod for Monthly Leqembi Maintenance Amid Stagnant Sales
BioPharma Dive
Mon, 01/27/25 - 11:24 am
Biogen
Eisai
Leqembi
Alzheimer's disease
FDA
US/EU regulators start review of Biogen's high-dose Spinraza
Pharmaphorum
Thu, 01/23/25 - 11:39 am
Biogen
Spinraza
SMQA
Biogen research team hit by layoffs as company shifts resources to external opportunities
Fierce Biotech
Wed, 01/22/25 - 07:29 pm
Biogen
R&D
layoffs
Sage sues Biogen as analyst detects little interest in buyout at original offer price
Fierce Pharma
Tue, 01/21/25 - 07:02 pm
SAGE Therapeutics
legal
Biogen
M&A
zuranolone
Federal watchdog cites concerns with FDA’s accelerated approval process
BioPharma Dive
Wed, 01/15/25 - 11:48 pm
HHS
FDA
accelerated approvals
Aduhelm
Biogen
Under pressure to deal, Biogen executives deflect urgency at JPM25
BioSpace
Wed, 01/15/25 - 11:33 am
Biogen
JPMHC 2025
M&A
Chris Viehbacher
SAGE Therapeutics
Sage Therapeutics Stock Soars as Biogen Makes Unsolicited Takeover Bid
Yahoo/Investopedia
Mon, 01/13/25 - 10:54 am
SAGE Therapeutics
Biogen
M&A
Alzheimer’s disease market expected to reach $19.3bn across the 8MM by 2033
Clinical Trials Arena
Fri, 01/10/25 - 11:18 am
Alzheimer's disease
Eisai
Biogen
Eli Lilly
Alzheon
Private Medicare plans must cover Biogen's ALS drug, US agency says
Yahoo/Reuters
Thu, 12/12/24 - 11:45 pm
CMS
Medicare
Biogen
ALS
Qalsody
How a Biogen drug set the stage for a new biotech targeting ALS
BioPharma Dive
Sun, 11/17/24 - 09:27 pm
Biogen
Trace Neuroscience
Qalsody
ALS
Eisai wins over European regulators on Alzheimer’s drug Leqembi
BioPharma Dive
Thu, 11/14/24 - 10:28 pm
Eisai
Biogen
Leqembi
Alzheimer's disease
5 Reasons Biogen’s Shares Have Dropped 36% in 2024
BioSpace
Thu, 11/14/24 - 11:19 am
Biogen
Leqembi
Qalsody
Skyclary
Zurzuvae
Spinraza
Eisai Cuts Fiscal 2024 Guidance for Biogen-Partnered Leqembi as Sales Disappoint Analysts
BioSpace
Sun, 11/10/24 - 09:27 pm
Eisai
Biogen
Leqembi
earnings
Alzheimer's disease
Eisai, Biogen eye 2025 approval for Leqembi autoinjector
Pharmaphorum
Fri, 11/1/24 - 10:57 am
Eisai
Biogen
Leqembi
Alzheimer's disease
FDA
Big Pharma earnings hang hope on the next generation of blockbusters
Pharma Voice
Thu, 10/31/24 - 09:19 am
Pfizer
JNJ
Biogen
Novartis
earnings
Biogen buys in to molecular glues with Neomorph deal worth up to $1.45B
Fierce Biotech
Wed, 10/30/24 - 08:45 pm
Biogen
Neomorph
molecular glue
protein degradation
Biogen, Sage admit a defeat in major depression
BioPharma Dive
Wed, 10/30/24 - 08:43 pm
Biogen
SAGE Therapeutics
Zurzuvae
postpartum depression
major depressive disorder
Biogen C-suite shuffle: CFO retires and chief medical officer joins
Medical Marketing and Media
Tue, 10/29/24 - 08:02 pm
Biogen
executives
Biogen shows its IgAN hand with felzartamab data
Pharmaphorum
Mon, 10/28/24 - 10:19 am
Biogen
clinical trials
kidney disease
felzartamab
IgA nephropathy

Pages